79 research outputs found

    Unsatisfying Wars: Degrees of Risk and the \u3ci\u3eJus ex Bello\u3c/i\u3e

    Get PDF
    Self-defensive war uses violence to transfer risks from one’s own people to others. We argue that central questions in just war theory may fruitfully be analyzed as issues about the morality of risk transfer. That includes the jus ex bello question of when states are required to accept a ceasefire in an otherwise-just war. In particular, a “war on terror” that ups the risks to outsiders cannot continue until the risk of terrorism has been reduced to zero or near zero. Some degree of security risk is inevitable when coexisting with others in the international community, just as citizens within a state must accept some ineradicable degree of crime as a fact of community life. We define a conception of morally legitimate bearable risk by contrasting it with two alternatives, and argue that states must stop fighting when they have achieved that level. We call this requirement the Principle of Just Management of Military Risk. We also argue that states should avoid exaggerated emphasis on security risks over equivalent risks from other sources—the Principle of Minimum Consistency Toward Risks. This latter principle is not a moral requirement. Rather, it is a heuristic intended to correct against well-known fallacies of risk perception that may lead states to overemphasize security risks and wrongly export the costs of their security onto others. In conclusion, we suggest that states must invest in non-violent defensive means as a precondition for legitimately using force externally

    The Dispensable Lives of Soldiers

    Get PDF

    The Shadow of Success: How International Criminal Law Has Come to Shape the Battlefield

    Get PDF
    The rise of international criminal law (ICL) has undoubtedly contributed to the development and enforcement of international humanitarian law (IHL). Yet, there are also important and oft-overlooked ways in which it has done the opposite. By labeling certain violations of the laws of war as “criminal” and setting up dedicated mechanisms for prosecution and punishment of offenders, the content, practice, and logic of ICL are displacing those of IHL. With its doctrinal precision, elaborate institutions, and the seemingly irresistible claim of political and moral priority, ICL is overshadowing the more diffuse, less institutionalized, and more difficult to enforce IHL. But if ICL becomes the dominant lens through which battlefield activity is measured, it is not merely intellectually unsatisfying; it poses a serious risk to the attainment of the very same humanitarian values that ICL seeks to protect. Consider the fact that in many wars fought today, the majority of civilian deaths and injuries does not result from acts that could be classified as war crimes, but from the more “mundane” choices of means and methods of warfare that at most would lend themselves to IHL scrutiny. Rather than diminishing the importance of ICL, this article calls for more attention to the ways in which ICL is impacting IHL as well as for a stronger commitment by States to the application and enforcement of IHL for its own sake

    Celiac Disease: Current and Investigational Therapies and the Role of the Pharmacist

    Get PDF
    Celiac disease is a genetically-linked autoimmune disease which affects the gastrointestinal tract. It is an inflammatory reaction to ingested gluten-containing substances that produces the most frequent symptoms of abdominal pain, bloating and intermittent or chronic diarrhea. Diagnosis can be made by blood testing for specific IgA autoantibodies and a confirmation duodenal biopsy to look for the characteristic scalloping and villous atrophy that occurs in response to the inflammation. A gluten-free diet, until recently, was the only treatment available and continues to be the mainstay of treatment. Newer adjunct therapies to dietary management include larazotide acetate, peptidases, the use of parasite Necator americanus, a desensitizing vaccine, polymeric binders, cytokine antagonists, tissue transglutaminase inhibitors, probiotics and anti-inflammatory therapy. This review will outline the potential of each of these therapies and discuss the role of the pharmacist in assisting patients with Celiac disease
    corecore